Welcome Bellevision com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from Daily Mail and Mail on Sunday newspapers.
India News: HYDERABAD: Amid a growing clamour for Bharat Biotech to declare the final data of the Phase-III trials of indigenously developed Covid-19 vaccine Cova.
Representative image
HYDERABAD: Bharat Biotech will be conducting phase-4 clinical trials of indigenously developed Covaxin to check its real-world effectiveness. It will also apply for full licensure for Covaxin only after it gets final analysis data of phase-3 studies, the company said on Wednesday.
According to the company, the phase-4 trials will not just help check the real-world effectiveness but also ensure that “its vaccine met every rigorous scientific standard for safety, effectiveness, and manufacturing quality needed to support emergency use authorization (EUA)”.
“It is important to note, the inoculation which began in mid-January and with several million doses administered, will have credible and sizable data soon,” it said.
India News: A ‘real-world’ study of vaccinated healthcare workers has found Covishield and Covaxin could produce a high immune response in up to 95% recipients an
Read more about Covishield shows better antibody response than Covaxin, says study on Business Standard. The study was aimed at analysing the antibody response after two complete doses of Covishield and Covaxin in Indians